• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
RAC

RACE ONCOLOGY LTD - Announcements

0.82% ! $1.22
Market Cap $212.8M  !

Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a... Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a dedicated mission to be at the heart of cancer care.More

Corporate Spotlight

Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a dedicated mission to be at the heart of cancer care.
View the full Corporate Spotlight arrow Created with Sketch.

RAC Accelerates Game-Changing Cancer Drug

Announcements



RAC Notification of cessation of securities - RAC05/08/22 download Created with Sketch. 21.64KB
RAC Update - Notification of buy-back - RAC02/08/22 download Created with Sketch. 24.78KB
RAC Update - Notification of buy-back - RAC28/07/22 download Created with Sketch. 24.78KB
RAC RAC Quarterly Investor Presentation27/07/22 download Created with Sketch. 1.47MB
RAC Update - Notification of buy-back - RAC27/07/22 download Created with Sketch. 24.78KB
RAC Update - Notification of buy-back - RAC26/07/22 download Created with Sketch. 24.76KB
RAC Race investor briefing invitation22/07/22 download Created with Sketch. 60.94KB
RAC Quarterly Activity Report & Appendix 4CPRICE SENSITIVE22/07/22 download Created with Sketch. 382.73KB
RAC Zantrene Protects Mouse Hearts from Chemotherapy DamagePRICE SENSITIVE30/06/22 download Created with Sketch. 1.4MB
RAC Zantrene shows synergy with kinase inhibitors in melanomaPRICE SENSITIVE28/06/22 download Created with Sketch. 1.79MB
RAC Zantrene Improves Immune Therapy Treatment of MelanomaPRICE SENSITIVE22/06/22 download Created with Sketch. 1014.98KB
RAC Zantrene data published in Cancer Research Journal21/06/22 download Created with Sketch. 118.43KB
RAC Notification of buy-back - RAC09/06/22 download Created with Sketch. 22.08KB
RAC Race Oncology Announces On-Market Share BuybackPRICE SENSITIVE09/06/22 download Created with Sketch. 91.49KB
RAC EMD AML MDS Trial Expands to EuropePRICE SENSITIVE08/06/22 download Created with Sketch. 362.22KB
RAC Zantrene AML trial in Israel advances to Phase 2PRICE SENSITIVE27/05/22 download Created with Sketch. 196.95KB
RAC Trading HaltPRICE SENSITIVE26/05/22 download Created with Sketch. 545.91KB
RAC Pause in TradingPRICE SENSITIVE26/05/22 download Created with Sketch. 115.78KB
RAC Dr Guy Breitenbucher joins Race SAB18/05/22 download Created with Sketch. 159.46KB
RAC Appendix 3Y - Mary Harney16/05/22 download Created with Sketch. 207.39KB
RAC Appendix 3Y - Dr Daniel Tillett16/05/22 download Created with Sketch. 205.37KB
RAC Appendix 3Y - Phillip Lynch16/05/22 download Created with Sketch. 208.05KB
RAC Appendix 3Y - Dr John Cullity16/05/22 download Created with Sketch. 225.2KB
RAC Notification of cessation of securities - RAC16/05/22 download Created with Sketch. 21.69KB
RAC Race Receives Governance Approval for AML EMD & MDS TrialPRICE SENSITIVE12/05/22 download Created with Sketch. 158.97KB
RAC Quarterly Activity Report & Appendix 4CPRICE SENSITIVE21/04/22 download Created with Sketch. 383.15KB
RAC CEO & CSO Employment Update12/04/22 download Created with Sketch. 92.34KB
RAC Becoming a substantial holder08/04/22 download Created with Sketch. 127.62KB
RAC Race receives Human Ethics AML Trial ApprovalPRICE SENSITIVE06/04/22 download Created with Sketch. 174.68KB
RAC Preclinical & Clinical Programs Update31/03/22 download Created with Sketch. 76.46KB
RAC Supply Agreement for EMD AML TrialPRICE SENSITIVE30/03/22 download Created with Sketch. 111.72KB
RAC Zantrene highly effective in EMD AML Mouse ModelPRICE SENSITIVE17/03/22 download Created with Sketch. 1.42MB
RAC Race ASX Small and Mid-Cap Conference Presentation15/03/22 download Created with Sketch. 4.38MB
RAC Compelling Zantrene Preclinical Kidney Cancer DataPRICE SENSITIVE10/03/22 download Created with Sketch. 1.79MB
RAC Cleansing Notice07/03/22 download Created with Sketch. 118.02KB
RAC Application for quotation of securities - RAC07/03/22 download Created with Sketch. 24.91KB
RAC Appendix 3Y - Dr Daniel Tillett04/03/22 download Created with Sketch. 205.63KB
RAC Appendix 4D & Half-Year Financial StatementsPRICE SENSITIVE25/02/22 download Created with Sketch. 908.64KB
RAC MD Anderson Preclinical AML Study on Zantrene PublishedPRICE SENSITIVE23/02/22 download Created with Sketch. 97.94KB
RAC Appointment of Chief Financial Officer31/01/22 download Created with Sketch. 58.57KB
RAC Quarterly Activity Report & Appendix 4CPRICE SENSITIVE28/01/22 download Created with Sketch. 597.56KB
RAC Race Receives FY2021 $708k R&D Tax Refund18/01/22 download Created with Sketch. 95.38KB
RAC Appendix 3Y - Dr John Cullity10/01/22 download Created with Sketch. 285.13KB
RAC Ceasing to be a substantial holder24/12/21 download Created with Sketch. 37.23KB
RAC Ceasing to be a substantial holder24/12/21 download Created with Sketch. 155.22KB
RAC Change in substantial holding21/12/21 download Created with Sketch. 124.39KB
RAC Appendix 3Y - Dr Daniel Tillett21/12/21 download Created with Sketch. 206.57KB
RAC Appendix 3Y - Mary Harney21/12/21 download Created with Sketch. 207.53KB
RAC Appendix 3Y - Phillip Lynch21/12/21 download Created with Sketch. 208.19KB
RAC Application for quotation of securities - RAC21/12/21 download Created with Sketch. 24.74KB
RAC Race raises $29.7 million in oversubscribed SPPPRICE SENSITIVE21/12/21 download Created with Sketch. 102.65KB
RAC Change of Registry Address20/12/21 download Created with Sketch. 152.9KB
RAC Appendix 3Y - Dr Daniel Tillett17/12/21 download Created with Sketch. 206.39KB
RAC SPP Closing Deadline Reminder & Investor Briefing Recording14/12/21 download Created with Sketch. 126.34KB
RAC Appendix 3Y - Dr Daniel Tillett13/12/21 download Created with Sketch. 207.54KB
RAC Uni of Newcastle Heart Protection Collaboration Extended10/12/21 download Created with Sketch. 116.9KB
RAC Expanded Heart Protection Discovery for ZantrenePRICE SENSITIVE08/12/21 download Created with Sketch. 478.7KB
RAC Notification regarding unquoted securities - RAC03/12/21 download Created with Sketch. 27.22KB
RAC Race online Q&A investor briefing invitation30/11/21 download Created with Sketch. 64.7KB
RAC Ceasing to be a substantial holder29/11/21 download Created with Sketch. 998.37KB
RAC Change in substantial holding29/11/21 download Created with Sketch. 1.01MB
RAC Race Oncology Investor Presentation - November 2021PRICE SENSITIVE23/11/21 download Created with Sketch. 9.02MB
RAC Race Oncology Share Purchase Plan Opens23/11/21 download Created with Sketch. 513.97KB
RAC Cleansing Notice Pursuant to Share Purchase Plan23/11/21 download Created with Sketch. 172.3KB
RAC Proposed issue of securities - RAC23/11/21 download Created with Sketch. 28.06KB
RAC Race Oncology Share Purchase PlanPRICE SENSITIVE23/11/21 download Created with Sketch. 83.88KB
RAC Results of Annual General Meeting23/11/21 download Created with Sketch. 98.71KB
RAC AGM PresentationsPRICE SENSITIVE23/11/21 download Created with Sketch. 3.19MB
RAC Trading HaltPRICE SENSITIVE23/11/21 download Created with Sketch. 225.88KB
RAC Breakthrough Zantrene Heart Protection DiscoveryPRICE SENSITIVE22/11/21 download Created with Sketch. 1.24MB
RAC Appendix 3Y - Dr John Cullity12/11/21 download Created with Sketch. 225.3KB
RAC Cleansing Notice12/11/21 download Created with Sketch. 118.08KB
RAC Application for quotation of securities - RAC12/11/21 download Created with Sketch. 27.59KB
RAC University of Wollongong R&D CollaborationPRICE SENSITIVE09/11/21 download Created with Sketch. 121.33KB
RAC Appendix 3Y - Dr John Cullity04/11/21 download Created with Sketch. 291.29KB
RAC Companion Diagnostic Study Initiated with UON03/11/21 download Created with Sketch. 111.6KB
RAC Ethics submission to commence Phase 2 AML EMD Trial01/11/21 download Created with Sketch. 178.99KB
RAC Quarterly Activity Report & Appendix 4CPRICE SENSITIVE28/10/21 download Created with Sketch. 374.46KB
RAC Race-Chaim Sheba FTO Biomarker Collaboration27/10/21 download Created with Sketch. 144.71KB
RAC Annual Report to shareholders21/10/21 download Created with Sketch. 4.76MB
RAC Letter to Shareholders & Notice of Annual General Meeting21/10/21 download Created with Sketch. 1.01MB
RAC Race secures sixth US patent for ZantrenePRICE SENSITIVE19/10/21 download Created with Sketch. 63.01KB
RAC Trading Policy Update13/10/21 download Created with Sketch. 134.7KB
RAC Race secures fifth US patent for ZantrenePRICE SENSITIVE06/10/21 download Created with Sketch. 60.34KB
RAC Date of AGM & Closing Date for Director Nominations05/10/21 download Created with Sketch. 52.58KB
RAC Preclinical & Clinical Programs UpdatePRICE SENSITIVE30/09/21 download Created with Sketch. 71.09KB
RAC Zantrene highly effective in Melanoma preclinical studyPRICE SENSITIVE30/09/21 download Created with Sketch. 827.42KB
RAC Appendix 3Y - Dr John Cullity03/09/21 download Created with Sketch. 296.4KB
RAC Annual Report-ASX Additonal Information Updated27/08/21 download Created with Sketch. 4.82MB
RAC Appendix 4G26/08/21 download Created with Sketch. 198.02KB
RAC Appendix 4E & Annual ReportPRICE SENSITIVE26/08/21 download Created with Sketch. 4.99MB
RAC Appendix 3Y - Dr John Cullity23/08/21 download Created with Sketch. 81.18KB
RAC Cleansing Notice23/08/21 download Created with Sketch. 116.68KB
RAC Application for quotation of securities - RAC23/08/21 download Created with Sketch. 24.93KB
RAC First Patient Dosed in Phase 1b/2 AML TrialPRICE SENSITIVE09/08/21 download Created with Sketch. 117.45KB
RAC Change in substantial holding03/08/21 download Created with Sketch. 292.69KB
RAC Quarterly Activity Report & Appendix 4CPRICE SENSITIVE29/07/21 download Created with Sketch. 314.92KB
RAC Notification regarding unquoted securities - RAC12/07/21 download Created with Sketch. 27.12KB
RAC Cleansing Notice06/07/21 download Created with Sketch. 116.96KB
RAC Application for quotation of securities - RAC06/07/21 download Created with Sketch. 24.87KB
RAC Notification of cessation of securities - RAC
05/08/22 download Created with Sketch. 21.64KB
RAC Update - Notification of buy-back - RAC
02/08/22 download Created with Sketch. 24.78KB
RAC Update - Notification of buy-back - RAC
28/07/22 download Created with Sketch. 24.78KB
RAC RAC Quarterly Investor Presentation
27/07/22 download Created with Sketch. 1.47MB
RAC Update - Notification of buy-back - RAC
27/07/22 download Created with Sketch. 24.78KB
RAC Update - Notification of buy-back - RAC
26/07/22 download Created with Sketch. 24.76KB
RAC Race investor briefing invitation
22/07/22 download Created with Sketch. 60.94KB
RAC Quarterly Activity Report & Appendix 4C
22/07/22PRICE SENSITIVE download Created with Sketch. 382.73KB
RAC Zantrene Protects Mouse Hearts from Chemotherapy Damage
30/06/22PRICE SENSITIVE download Created with Sketch. 1.4MB
RAC Zantrene shows synergy with kinase inhibitors in melanoma
28/06/22PRICE SENSITIVE download Created with Sketch. 1.79MB
RAC Zantrene Improves Immune Therapy Treatment of Melanoma
22/06/22PRICE SENSITIVE download Created with Sketch. 1014.98KB
RAC Zantrene data published in Cancer Research Journal
21/06/22 download Created with Sketch. 118.43KB
RAC Notification of buy-back - RAC
09/06/22 download Created with Sketch. 22.08KB
RAC Race Oncology Announces On-Market Share Buyback
09/06/22PRICE SENSITIVE download Created with Sketch. 91.49KB
RAC EMD AML MDS Trial Expands to Europe
08/06/22PRICE SENSITIVE download Created with Sketch. 362.22KB
RAC Zantrene AML trial in Israel advances to Phase 2
27/05/22PRICE SENSITIVE download Created with Sketch. 196.95KB
RAC Trading Halt
26/05/22PRICE SENSITIVE download Created with Sketch. 545.91KB
RAC Pause in Trading
26/05/22PRICE SENSITIVE download Created with Sketch. 115.78KB
RAC Dr Guy Breitenbucher joins Race SAB
18/05/22 download Created with Sketch. 159.46KB
RAC Appendix 3Y - Mary Harney
16/05/22 download Created with Sketch. 207.39KB
RAC Appendix 3Y - Dr Daniel Tillett
16/05/22 download Created with Sketch. 205.37KB
RAC Appendix 3Y - Phillip Lynch
16/05/22 download Created with Sketch. 208.05KB
RAC Appendix 3Y - Dr John Cullity
16/05/22 download Created with Sketch. 225.2KB
RAC Notification of cessation of securities - RAC
16/05/22 download Created with Sketch. 21.69KB
RAC Race Receives Governance Approval for AML EMD & MDS Trial
12/05/22PRICE SENSITIVE download Created with Sketch. 158.97KB
RAC Quarterly Activity Report & Appendix 4C
21/04/22PRICE SENSITIVE download Created with Sketch. 383.15KB
RAC CEO & CSO Employment Update
12/04/22 download Created with Sketch. 92.34KB
RAC Becoming a substantial holder
08/04/22 download Created with Sketch. 127.62KB
RAC Race receives Human Ethics AML Trial Approval
06/04/22PRICE SENSITIVE download Created with Sketch. 174.68KB
RAC Preclinical & Clinical Programs Update
31/03/22 download Created with Sketch. 76.46KB
RAC Supply Agreement for EMD AML Trial
30/03/22PRICE SENSITIVE download Created with Sketch. 111.72KB
RAC Zantrene highly effective in EMD AML Mouse Model
17/03/22PRICE SENSITIVE download Created with Sketch. 1.42MB
RAC Race ASX Small and Mid-Cap Conference Presentation
15/03/22 download Created with Sketch. 4.38MB
RAC Compelling Zantrene Preclinical Kidney Cancer Data
10/03/22PRICE SENSITIVE download Created with Sketch. 1.79MB
RAC Cleansing Notice
07/03/22 download Created with Sketch. 118.02KB
RAC Application for quotation of securities - RAC
07/03/22 download Created with Sketch. 24.91KB
RAC Appendix 3Y - Dr Daniel Tillett
04/03/22 download Created with Sketch. 205.63KB
RAC Appendix 4D & Half-Year Financial Statements
25/02/22PRICE SENSITIVE download Created with Sketch. 908.64KB
RAC MD Anderson Preclinical AML Study on Zantrene Published
23/02/22PRICE SENSITIVE download Created with Sketch. 97.94KB
RAC Appointment of Chief Financial Officer
31/01/22 download Created with Sketch. 58.57KB
RAC Quarterly Activity Report & Appendix 4C
28/01/22PRICE SENSITIVE download Created with Sketch. 597.56KB
RAC Race Receives FY2021 $708k R&D Tax Refund
18/01/22 download Created with Sketch. 95.38KB
RAC Appendix 3Y - Dr John Cullity
10/01/22 download Created with Sketch. 285.13KB
RAC Ceasing to be a substantial holder
24/12/21 download Created with Sketch. 37.23KB
RAC Ceasing to be a substantial holder
24/12/21 download Created with Sketch. 155.22KB
RAC Change in substantial holding
21/12/21 download Created with Sketch. 124.39KB
RAC Appendix 3Y - Dr Daniel Tillett
21/12/21 download Created with Sketch. 206.57KB
RAC Appendix 3Y - Mary Harney
21/12/21 download Created with Sketch. 207.53KB
RAC Appendix 3Y - Phillip Lynch
21/12/21 download Created with Sketch. 208.19KB
RAC Application for quotation of securities - RAC
21/12/21 download Created with Sketch. 24.74KB
RAC Race raises $29.7 million in oversubscribed SPP
21/12/21PRICE SENSITIVE download Created with Sketch. 102.65KB
RAC Change of Registry Address
20/12/21 download Created with Sketch. 152.9KB
RAC Appendix 3Y - Dr Daniel Tillett
17/12/21 download Created with Sketch. 206.39KB
RAC SPP Closing Deadline Reminder & Investor Briefing Recording
14/12/21 download Created with Sketch. 126.34KB
RAC Appendix 3Y - Dr Daniel Tillett
13/12/21 download Created with Sketch. 207.54KB
RAC Uni of Newcastle Heart Protection Collaboration Extended
10/12/21 download Created with Sketch. 116.9KB
RAC Expanded Heart Protection Discovery for Zantrene
08/12/21PRICE SENSITIVE download Created with Sketch. 478.7KB
RAC Notification regarding unquoted securities - RAC
03/12/21 download Created with Sketch. 27.22KB
RAC Race online Q&A investor briefing invitation
30/11/21 download Created with Sketch. 64.7KB
RAC Ceasing to be a substantial holder
29/11/21 download Created with Sketch. 998.37KB
RAC Change in substantial holding
29/11/21 download Created with Sketch. 1.01MB
RAC Race Oncology Investor Presentation - November 2021
23/11/21PRICE SENSITIVE download Created with Sketch. 9.02MB
RAC Race Oncology Share Purchase Plan Opens
23/11/21 download Created with Sketch. 513.97KB
RAC Cleansing Notice Pursuant to Share Purchase Plan
23/11/21 download Created with Sketch. 172.3KB
RAC Proposed issue of securities - RAC
23/11/21 download Created with Sketch. 28.06KB
RAC Race Oncology Share Purchase Plan
23/11/21PRICE SENSITIVE download Created with Sketch. 83.88KB
RAC Results of Annual General Meeting
23/11/21 download Created with Sketch. 98.71KB
RAC AGM Presentations
23/11/21PRICE SENSITIVE download Created with Sketch. 3.19MB
RAC Trading Halt
23/11/21PRICE SENSITIVE download Created with Sketch. 225.88KB
RAC Breakthrough Zantrene Heart Protection Discovery
22/11/21PRICE SENSITIVE download Created with Sketch. 1.24MB
RAC Appendix 3Y - Dr John Cullity
12/11/21 download Created with Sketch. 225.3KB
RAC Cleansing Notice
12/11/21 download Created with Sketch. 118.08KB
RAC Application for quotation of securities - RAC
12/11/21 download Created with Sketch. 27.59KB
RAC University of Wollongong R&D Collaboration
09/11/21PRICE SENSITIVE download Created with Sketch. 121.33KB
RAC Appendix 3Y - Dr John Cullity
04/11/21 download Created with Sketch. 291.29KB
RAC Companion Diagnostic Study Initiated with UON
03/11/21 download Created with Sketch. 111.6KB
RAC Ethics submission to commence Phase 2 AML EMD Trial
01/11/21 download Created with Sketch. 178.99KB
RAC Quarterly Activity Report & Appendix 4C
28/10/21PRICE SENSITIVE download Created with Sketch. 374.46KB
RAC Race-Chaim Sheba FTO Biomarker Collaboration
27/10/21 download Created with Sketch. 144.71KB
RAC Annual Report to shareholders
21/10/21 download Created with Sketch. 4.76MB
RAC Letter to Shareholders & Notice of Annual General Meeting
21/10/21 download Created with Sketch. 1.01MB
RAC Race secures sixth US patent for Zantrene
19/10/21PRICE SENSITIVE download Created with Sketch. 63.01KB
RAC Trading Policy Update
13/10/21 download Created with Sketch. 134.7KB
RAC Race secures fifth US patent for Zantrene
06/10/21PRICE SENSITIVE download Created with Sketch. 60.34KB
RAC Date of AGM & Closing Date for Director Nominations
05/10/21 download Created with Sketch. 52.58KB
RAC Preclinical & Clinical Programs Update
30/09/21PRICE SENSITIVE download Created with Sketch. 71.09KB
RAC Zantrene highly effective in Melanoma preclinical study
30/09/21PRICE SENSITIVE download Created with Sketch. 827.42KB
RAC Appendix 3Y - Dr John Cullity
03/09/21 download Created with Sketch. 296.4KB
RAC Annual Report-ASX Additonal Information Updated
27/08/21 download Created with Sketch. 4.82MB
RAC Appendix 4G
26/08/21 download Created with Sketch. 198.02KB
RAC Appendix 4E & Annual Report
26/08/21PRICE SENSITIVE download Created with Sketch. 4.99MB
RAC Appendix 3Y - Dr John Cullity
23/08/21 download Created with Sketch. 81.18KB
RAC Cleansing Notice
23/08/21 download Created with Sketch. 116.68KB
RAC Application for quotation of securities - RAC
23/08/21 download Created with Sketch. 24.93KB
RAC First Patient Dosed in Phase 1b/2 AML Trial
09/08/21PRICE SENSITIVE download Created with Sketch. 117.45KB
RAC Change in substantial holding
03/08/21 download Created with Sketch. 292.69KB
RAC Quarterly Activity Report & Appendix 4C
29/07/21PRICE SENSITIVE download Created with Sketch. 314.92KB
RAC Notification regarding unquoted securities - RAC
12/07/21 download Created with Sketch. 27.12KB
RAC Cleansing Notice
06/07/21 download Created with Sketch. 116.96KB
RAC Application for quotation of securities - RAC
06/07/21 download Created with Sketch. 24.87KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$1.22
Change
-0.010(0.82%)
Mkt cap ! $212.8M
Open High Low Value Volume
$1.24 $1.25 $1.19 $177.7K 146.9K

Buyers (Bids)

No. Vol. Price($)
2 1055 $1.20
 

Sellers (Offers)

Price($) Vol. No.
$1.22 1915 1
View Market Depth
Last trade - 14.24pm 11/08/2025 (20 minute delay) ?
Last
$1.20
  Change
-0.010 ( 1.64 %)
Open High Low Volume
$1.23 $1.25 $1.20 16447
Last updated 14.10pm 11/08/2025 ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.